Clinical trial
US 10 mL Biologic Lung Volume Reduction (BLVR) Phase 2 Emphysema Study
NCT00435253 · Aeris Therapeutics, Industry · Completed
Key facts
| NCT number | NCT00435253 |
|---|---|
| Title | US 10 mL Biologic Lung Volume Reduction (BLVR) Phase 2 Emphysema Study |
| Official title | Phase 2 Study of the Biologic Lung Volume Reduction System (BLVR) in Patients With Advanced Upper Lobe Predominant Emphysema |
| Lead sponsor | Aeris Therapeutics, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pulmonary Emphysema |
| Intervention type | Biological |
| Interventions | BLVR Treatment |
| Enrollment | 20 |
| Start date | Feb 1, 2007 |
| Primary completion | Jun 1, 2009 |
| Completion | Jun 1, 2009 |
| First posted | Feb 14, 2007 |
| Last update posted | Oct 24, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: